A multinational, multicentre, non-blinded, randomized study of moxifloxacin oral tablets compared with co-amoxiclav oral tablets in the treatment of acute exacerbation of chronic bronchitis

Journal of International Medical Research

Volumn 29, Issue 4, 2001, Pages 314-328

  Schaberg, T ^a   Ballin, I ^a   Huchon, G ^a   Bassaris, H ^a   Hampel, B ^a   Reimnitz, P ^a   Kummer, F ^a   Wetter, N ^a   Delpire, P ^a   Deruyttere, M ^a   Martinot, J B ^a   Llorens, P L ^a   Albesa, F ^a   Bart, F ^a   Bernabeu, L ^a   Royer, F ^a   Foquert, L ^a   Simmons, A ^a   Martinat, Y ^a   Meridjen, G ^a   Francon, R ^a   Zuck, P ^a   Godard, P ^a   Boyer, G R ^a   Cerwicz, O ^a   Colberg, K ^a   Linnehoff, A ^a   McDaniel, A ^a   Mitlehner, W ^a   Schnorr, R ^a   Schultz, T ^a   Szerdahelyi, U ^a   Von Versen, L H ^a   Westerhausen, U ^a   Todoroff, K ^a   more..

^a Kliniken der Stadt Kö Ln GGmbH   (Germany)

Author keywords

Bacterial infection; Chronic bronchitis; Co amoxiclav; Moxifloxacin; Oral therapy; Safety

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFUROXIME AXETIL; MOXIFLOXACIN; STEROID; TROVAFLOXACIN;

ABDOMINAL PAIN; ADULT; ADVERSE DRUG REACTION; AGED; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATION; CHRONIC BRONCHITIS; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; COUGHING; DIARRHEA; DISEASE EXACERBATION; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; DYSPNEA; ERADICATION THERAPY; FEMALE; HAEMOPHILUS INFLUENZAE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORAXELLA CATARRHALIS; MULTICENTER STUDY; NAUSEA; PARAMETER; RANDOMIZED CONTROLLED TRIAL; SPUTUM; STATISTICAL ANALYSIS; STREPTOCOCCUS PNEUMONIAE; SYMPTOM; TABLET; VERTIGO; WHEEZING;

EID: 0034811145     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000102900408     Document Type: Article

References (26)

1. Epidemiology and treatment of chronic bronchitis and its exacerbations
2. Infection in acute exacerbations of chronic bronchitis: A clinical perspective
3. The patient's burden: Physical and psychological effects of acute exacerbations of chronic bronchitis
4. Role of antimicrobials in the management of acute exacerbations of chronic bronchitis
5. Infectious exacerbations of chronic bronchitis: Diagnosis and management
6. Factors influencing clearance of bacteria by the lung
7. The damaging role of bacteria in chronic lung infection
8. Acute respiratory infections
9. Management of acute exacerbation of chronic bronchitis
10. Definitions and classification of chronic bronchitis, asthma, and pulmonary emphysema
11. Infectious etiology of acute exacerbations of chronic bronchitis
12. Acute exacerbations of chronic bronchitis: Focusing management for optimum results
13. Chemotherapy for chronic bronchitis. Controversies
14. Acute exacerbations of chronic bronchitis: Fluoroquinolone clinical trial review
15. Antibiotic therapy of exacerbations of chronic bronchitis
16. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease
17. Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis
18. In vitro activity of BAY 12-8039, a novel 8-methoxyquinolone, compared to activities of six fluoroquinolones against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis
19. Pharmacokinetics, safety, and tolerability of ascending single doses of moxifloxacin, a new 8-methoxy quinolone administered to healthy subjects
20. Concentrations of moxifloxacin in serum and pulmonary compartments following a single 400 mg oral dose in patients undergoing fibre-optic bronchoscopy
21. How to establish equivalence between treatments: A one-sided clinical trial in paediatric oncology
22. Endogenous and exogenous reinfections by Haemophilus influenzae in patients with chronic obstructive pulmonary disease: The effect of antibiotic treatment on persistence
23. Short-course moxifloxacin therapy for treatment of acute bacterial exacerbations of chronic bronchitis
24. Five day moxifloxacin therapy compared with 7 day clarithromycin therapy for the treatment of acute exacerbations of chronic bronchitis
25. The efficacy and tolerability of moxifloxacin compared to trovafloxacin in the treatment of acute sinusitis
26. Comparison of moxifloxacin and cefuroxime axetil in the treatment of acute maxillary sinusitis